Impact of treatment with acetylcholinesterase inhibitors, valproic acid and antipsychotics on aggressive behaviour in Alzheimer's type dementia;Wpływ farmakoterapii inhibitorami acetylocholinesterazy, kwasem walproinowym i lekami przeciwpsychotycznymi na zachowania agresywne w przebiegu otȩpienia typu Alzheimera

Psychiatria Polska

Volumn 46, Issue 3, 2012, Pages 361-372

  Bidzan, Leszek ^a   Grabowski, Jakub ^a   Dutczak, Beata ^a   Bidzan, Mariola ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

Aggression; Antipsychotics; Cholinesterase inhibitors; Dementia; Valproic acid

Indexed keywords

CHOLINESTERASE INHIBITOR; NEUROLEPTIC AGENT; VALPROIC ACID;

AGED; AGGRESSION; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT;

AGED; AGED, 80 AND OVER; AGGRESSION; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; COGNITION; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; POLAND; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84864125825     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Teri L, Rabins P, Whitehouse P, Berg L, Reisberg B, Sunderland T, Eichelman B, Phelps C. Management of behavior disturbance in Alzheimer disease: current knowledge and future directions. Alzheimer Dis. Assoc. Disord. 1992; 6: 77-88.
2. Menon AS, Gruber-Baldini AL, Hebel JR, Kaup B, Loreck D, Itkin Zimmerman S, Burton L, German P, Magaziner J. Relationship between aggressive behaviors and depression among nursing home residents with dementia. Int. J. Geriatr. Psychiatry 2001; 16: 139-146. (Pubitemid 32166304)
3. Cohen-Mansfield J, Marx MS, Rosenthal AS. Dementia and agitation in nursing home residents: how are they related? Psychol. Aging 1990; 5: 3-8.
4. Beck C, Frank L, Chumbler NR, O'Sullivan P, Vogelpohl TS, Rasin J, Walls R, Baldwin B. Correlates of disruptive behavior in severely cognitively impaired nursing home residents. Gerontologist 1998; 38: 189-198. (Pubitemid 28169629)
5. Walsh JS, Welch HG, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann. Intern. Med. 1990; 113: 429-434. (Pubitemid 20333450)
6. Moritz DJ, Fox PJ, Luscombe FA, Kraemer HC. Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California. Arch. Neurol. 1997; 54: 878-885. (Pubitemid 27306625)
7. Swearer JM, Drachmann DA, O'Donnel BF, Mitchell AL. Troublesome and disruptive behaviours in dementia - relationship to diagnosis and disease severity. J. Am. Geriatric Soc. 1988; 76: 784-790.
8. Petry S, Cummings JL, Hill MA, Shapira J. Personality alterations in dementia of the Alzheimer's type. Arch. Neurol. 1988; 45: 1187-1190.
9. Cohen-Mansfield J, Marx MS, Werner P. Agitation in elderly persons: an integrative report of findings in a nursing home. Int Psychogeriatr. 1992; 4 (supl. 2): 221-240.
10. Schreiner AS, Yamamoto E, Shiotani H. Agitated behavior in elderly nursing home residents with dementia in Japan. J. Gerontol Psychol. Sci. Soc. Sci. 2000; 55: 180-186.
11. Rosler M. The efficacy of cholinesterase inhibitors In treating the behavioural symptoms of dementia. IJCP 2002; 127 (supl): 20-36.
12. Herrmann N, Lanctôt KL, Lyla, Hon RK. The role of norepinephrine in the behavioral and psychological symptoms of dementia. J. Neuropsychiatry Clin. Neurosci. 2004; 16: 261-276. (Pubitemid 39244552)
13. Scarmeas N, Brandt J, Blacker D, Albert M, Hadjigeorgiou G, Dubois B, Devanand D, Honig L, Stern Y. Disruptive behavior as a predictor in Alzheimer disease. Arch. Neurol. 2007; 64: 1755-1761. (Pubitemid 350254938)
14. Cummings JL, Back C. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am. J. Geriatr. Psychiatry 1998; 6 (supl): 64-78.
15. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12: 189-198.
16. Mc Khan G., Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease:report ofthe NINCDS-ADRDA Work Group under the suspicies of Department of Health Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939.
17. Hachinski VC. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 1974; 2: 207-209.
18. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J. Gerontol. 1989; 44: M77-M84. (Pubitemid 19130580)
19. Bidzan L, Bidzan M. Ocena rzetelności i trafności polskiej wersji jȩzykowej skali pobudzenia Cohena-Mansfielda (The Cohen-Mansfield Agitation Inventory). Psychogeriatr. Pol. 2005; 2: 89-98.
20. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 1984; 141: 1356-1364.
21. Leber P. FDA guidance on Alzheimer's drug clinical utility assessments. Washington: F DA; 1992.
22. Lanctôt KL, Herrmann N, Mazzotta P. Role of serotonin in the behavioral and psychological symptoms of dementia. J. Neuropsychiatry Clin. Neurosci. 2001; 13: 5-21.
23. Redmond D. Studies of the nucleus locus ceruleus in monkeys and hypothesis for neuropsychopharmacology. W: Meltzer H. red. Psychopharmacology: The third generation of progress. New York: RavenPress; 1987. s. 967-975.
24. Friedman JI, Adler DN, Davis KL. The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol. Psychiatry 1999; 46: 1243-1252. (Pubitemid 30114441)
25. Lindenmayer JP. The pathophysiology of agitation. J. Clin. Psychiatry 2000; 61 (supl. 14): 5-10.
26. Bianchi C, Spidalieri G, Guandalini P, Tanganelli S, Beani L. Inhibition of acetylcholine outflow from guinea-pig cerebral cortex following locus coeruleus stimulation. Neurosci. Lett. 1979; 14: 97-100. (Pubitemid 10234002)
27. Leng Y, Chuang DM. Endogenous α-synuclein is potently induced by valproate and participates in the neuroprotection against glutamate excitotoxicity. J. Neurosci. 2006; 26: 7502-7512. (Pubitemid 44315219)